Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Neoplasms [C04] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DAUNORUBICIN | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |